The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
Journal of Medical Virology · 2025-12 · 97 (12)
DOI: 10.1002/jmv.70721 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 05.12.2025. Verfasst von Michael A McVoy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study is funded by Child Health Research Institute and Commonwealth Health Research Board..
Abstract (Originalsprache)
The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent infection or progression to life‐threatening disease. Angiotensin converting enzyme‐2 (ACE2) and its interaction with the SARS‐CoV‐2 Spike glycoprotein, which mediates fusion of the virion envelope with the target cell membrane, have emerged as a major pharmacological target, as disruption of the Spike‐ACE2 interaction prevents cells from becoming infected and hence from producing viral progeny. Moreover, the dysregulation of ACE2 that occurs in the context of SARS‐CoV‐2 infection may have broader implications for COVID‐19 pathogenesis. Here we summarize the role of ACE2 as a physiologic regulator of human health, as a facilitator of SARS‐CoV‐2 infection, as a factor in COVID‐19 disease, and as a target for pharmacological interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Virginia Commonwealth University, Richmond, Virginia, USA.
ORCID-Profile: Michael A McVoy
Förderung
- This study is funded by Child Health Research Institute and Commonwealth Health Research Board.
Zitieren
APA
McVoy, M. A., & Kummarapurugu, A. B. (2025). The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions. Journal of Medical Virology, 97(12). https://doi.org/10.1002/jmv.70721
Vancouver
McVoy MA, Kummarapurugu AB. The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions. Journal of Medical Virology. 2025;97(12). doi:10.1002/jmv.70721
BibTeX
@article{McVoy2025,
author = {McVoy, Michael A and Kummarapurugu, Apparao B},
title = {The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {12},
doi = {10.1002/jmv.70721}
}
EUVIMED